GENE duplication is one of the major driving forces for the evolution of novel gene function. It enables organisms to rapidly adapt to changing environments ([@bib58]; [@bib43]), and it is also important for speciation ([@bib47]). Large proportions (20--60%) of genes in all kingdoms of life are generated by gene duplication ([@bib65]; [@bib44]; [@bib83]). The birth rate of duplicated genes in eukaryotes has been estimated to be ∼1 gene^−1^ 100 MY^−1^ ([@bib46]), which is similar to their silent-site nucleotide substitution rate of ∼0.25--1.6 nt^−1^ 100 MY^−1^ ([@bib43]; [@bib46]). However, most duplicated genes are inactivated relatively quickly ([@bib74]). *Saccharomyces cerevisiae* contains duplicated genes that arose from an ancient whole genome duplication event ([@bib79]; [@bib34]), which was recently identified as an ancient interspecies hybridization event ([@bib50]). However, almost 90% of all duplicated genes were lost within a few million years at an estimated half-life of ∼1 MY ([@bib46], [@bib47]). The fate of duplicated genes depends on a number of factors. [@bib13]) reported preferential duplication of conserved genes, while genes encoding proteins of multi-protein complexes or dosage-sensitive genes were less likely to generate stable duplicates ([@bib60]). A comprehensive study by [@bib75] found that duplicated genes typically diverge with respect to regulatory control, but rarely in their biochemical function ([@bib75]). The authors concluded that gene duplication may eventually simplify, rather than increase, the complexity of a system by partial "division of labor." That is, "subfunctionalization" (SF) enables the optimization of overlapping functions of an ancestral protein ([@bib75]). However, in smaller populations, mutation and genetic drift can increase functional complexity without any necessary adaptive benefit to the organism ([@bib45]). The SF of a component of the fungal V-ATPase proton pump is a case in point ([@bib20]).

Gene conversion is a "copy and paste" function between highly similar (\>90%) sequences. It can occur between alleles, typically during meiosis (allelic gene conversion), but also occurs between paralogous, duplicated, genes during mitosis \[ectopic gene conversion, EGC ([@bib19])\]. EGC was first recognized as important for maintaining sequence identity between repeat copies of genes within the large rRNA gene cluster, prompting the generation of a model for the evolution of multi-gene families termed "concerted evolution" ([@bib7]). Many examples of multi-gene families (*e.g.*, histones, GPCRs, ubiquitins, immunoglobulins, and MHC genes) supposedly shaped by concerted evolution followed. However, this model does not explain how members of multi-gene families evolve novel functions, and why there are so many inactive pseudogenes (∼2--5% of yeast genes ([@bib39]) and \>10,000 in humans ([@bib84])). This prompted the formulation of the "birth-and-death" model, which suggested that new genes are created by gene duplication and some stay in the genome for a very long time, whereas most are inactivated or deleted from the genome ([@bib54]). The controversy over which of the two models best describes the evolution of multi-gene families continues ([@bib4]), partly because neither model explains the biological evidence satisfactorily.

Many factors affect the gene conversion rate such as genome location, the distance and similarity between similar tracts, and the minimum tract length or minimum efficient processing segment (MEPS)---the minimum length of highly similar repeat sequences required for homologous recombination. Most studies estimate the gene conversion rate to be ∼10--100 times higher than the synonymous nucleotide substitution rate ([@bib48]). The outcome of gene conversion can be either beneficial (*e.g.*, rRNA gene family) or harmful, with an increasing number of genetic disorders being ascribed to EGC ([@bib11]).

But how can duplicated genes evolve a novel function (*i.e.*, neo-functionalize) and fix an advantageous mutation(s) in a population when EGC is active? Population genetic theory indicates that strong selection against EGC is required for the stable maintenance of a mutation (*i.e.*, a fate determining mutation, as it provides an evolutionary advantage to the organism) ultimately resulting in the evolution of a novel function \[*i.e.*, neo-functionalization (NF)\] of a duplicated gene copy ([@bib30]). Gao and Innan noticed that the battle between these two opposing evolutionary forces (*i.e.*, maintenance of an advantageous mutation *vs.* frequent EGCs between tandem-duplicated genes) continues for a relatively long time ([@bib22]). This, ultimately, leads to a local peak of sequence divergence between these tandem-duplicates with low divergence in regions away from the mutation, and the outcome of NF in the face of EGC is a recognizable pattern of highly similar sequences interspersed by highly divergent sequences ([@bib59]; [@bib30]). A prominent example is the human red and green opsin genes that have arisen by gene duplication after the split of New and Old World monkeys ∼30--40 MYA with only two aa variations of exon 5 accounting for \>80% of the functional differences between the red and green eye pigments ([@bib53]; [@bib55]; [@bib78]; [@bib68]).

Although EGC, natural mutation, and positive Darwinian selection are important factors shaping the evolution of gene duplicates, and complex mathematical models can predict possible outcomes, more experimental data are needed to improve existing models ([@bib30]). Such data are hard to obtain because sequencing duplicated genes from a representative sample of individuals from higher eukaryotes is extremely difficult due to their large size and, often, complex gene arrangements, which makes it is almost impossible to correctly resolve such repeat sequences ([@bib5]). The discovery of an ancient pair of tandem-duplicated genes (*ABC1* and *ABC11*), encoding drug efflux pumps, undergoing prolonged concerted evolution in *Candida krusei* provided a rare opportunity to extract actual values for important evolutionary factors shaping the evolution of duplicated genes. Extensive polymorphism data from geographically diverse isolates gave novel insights into the population structure of *C. krusei*. They enabled direct estimates for the gene conversion rate and the size of the MEPS, and they confirmed "GC-bias" for gene conversion ([@bib21]; [@bib49]; [@bib57]) in *C. krusei*. Intramolecular gene deletions and intermolecular nonhomologous mitotic recombination between tandem-duplicates also caused copy number variations (CNV), and the formation of *ABC11-1* or *ABC1-11* chimeras with novel pump functions. The discovery of a third close homolog, *C. krusei* multidrug efflux pump *ABC12*, and discovery of *ABC11* and *ABC1* orthologs in the closest sequenced relative, *Pichia membranifaciens*, were crucial to tentatively infer the evolutionary history of all three *C. krusei* family members, and provided clues about the amino acid changes in Abc1p and Abc11p that were most likely fate-determining, and caused the evolution of two functionally distinct efflux pumps.

Materials and Methods {#s1}
=====================

Strains and culture conditions {#s2}
------------------------------

*C. krusei* isolates and yeast strains used in this study are listed in Supplemental Material, Table S1 in [File S1](http://www.genetics.org/highwire/filestream/436283/field_highwire_adjunct_files/12/FileS1.pdf). All *S. cerevisiae* strains created in this study are based on AD∆ ([@bib40]). Fungal strains were grown in yeast extract, peptone and glucose (YPD) medium: 1% (w/v) Bacto-yeast extract (Difco Laboratories, Detroit, MI), 2% (w/v) Bacto-peptone (Difco) and 2% (w/v) glucose. Yeast transformants were selected on plates containing 0.077% (w/v) complete supplement mixture without uracil (CSM-ura; Bio 101, Vista, CA), 0.67% (w/v) yeast nitrogen base without amino acids (Difco), 2% (w/v) glucose, and 2% (w/v) agar (Difco). Plasmids were maintained in *Escherichia coli* strain DH5α. *E. coli* cells were grown in Luria-Bertani (LB) medium, to which ampicillin was added (100 µg/ml) as required.

Materials {#s3}
---------

Molecular biology reagents, restriction and modifying enzymes were from New England Biolabs (Beverly, MA) or from Roche Diagnostics N.Z. (Auckland, New Zealand). Lyophilized desalted DNA oligonucleotides (Table S2 in [File S1](http://www.genetics.org/highwire/filestream/436283/field_highwire_adjunct_files/12/FileS1.pdf)) were purchased from Sigma-Aldrich Pty. (Sydney, Australia). PCR-amplified DNA fragments were purified using kits from Qiagen Pty. (Clifton Hill, Victoria, Australia). Genomic DNA (gDNA) was isolated from yeast using the Y-DER Yeast DNA Extraction Reagent Kit from Pierce (Rockford, IL), or the DNeasy Tissue Kit from Qiagen. Yeast were transformed using the alkali-cation yeast transformation kit from Bio 101 ([@bib40]). All plasmids and yeast transformants were verified by DNA-sequencing using the DYEnamic ET Terminator Cycle Sequencing kit v 3.1 (GE Healthcare UK, Little Chalfont, UK), and analyzed at the Micromon DNA Sequencing Facility (Monash University, Melbourne, Australia). PCR reactions used the high fidelity KOD^+^ DNA polymerase (Toyobo, Osaka, Japan, or Novagen, San Diego, CA).

Compounds {#s4}
---------

The chemicals and antifungal agents were purchased from the following sources: fluconazole (FLC; Diflucan; Pfizer Laboratories, Auckland, New Zealand), itraconazole (ITC; Janssen Research Foundation, Beerse, Belgium), aureobasidin A (AUR; Takara Bio, Shiga, Japan), clotrimazole (CLT; Bayer, Osaka, Japan), miconazole (MCZ), voriconazole (VRZ), rhodamine 6G (R6G), rhodamine 123 (R123), cycloheximide (CHX), nigericin (NIG), trifluoperazine (TFP), doxorubicin (DOX), daunorubicin (DAU), enniatin (ENI), and oligomycin (OLI) (Sigma-Aldrich New Zealand, Auckland, New Zealand). FK506 was a gift from Astellas Pharma (Tokyo, Japan), and the milbemycins α11, α20, β9, and β11 were a gift from Sankyo (Tokyo, Japan).

Multilocus sequence typing (MLST) {#s5}
---------------------------------

To determine the diploid sequence type (DST) for each isolate, we used the publicly available *C. krusei* MLST database (<http://pubmlst.org/ckrusei/>; [@bib32]). Using the recommended DNA primers, we PCR-amplified parts of the ORFs of six housekeeping genes (*HIS3*, *LEU2*, *NMT1*, *TRP1*, *ADE2*, and *LYS2*) from gDNA extracted from individual *C. krusei* strains, and sequenced the fragments in both directions with the same primers. Genotypes that were included in the database were numbered accordingly, and new genotypes were given new numbers by extending the count of identified genotypes.

Genetic manipulations {#s6}
---------------------

Plasmid pBluescriptIISK(+) (Stratagene, La Jolla, CA) was used to generate *ABC1* and *ABC11* subclones. Inverse PCR fragments were amplified from gDNA extracted from different *C. krusei* isolates as previously described ([@bib41]. In short, ∼1 µg of gDNA was digested to completion with restriction enzymes, purified by phenol extraction followed by ethanol precipitation, and redissolved in 100 µl of sterile milliQ water. The fully digested, purified, gDNA (∼50 ng) was then ligated (20 µl reaction) to form circular DNA molecules. Portions of the ligated gDNA mix (1 µl) were used as templates for inverse PCR reactions (50 µl). Inverse forward and reverse PCR primer pairs specific for *ABC11* (11-P1, 11-P2, and 11-P3), or *ABC1* (1-P3; [Figure S1B](http://www.genetics.org/highwire/filestream/436283/field_highwire_adjunct_files/0/FigureS1.pdf)) were designed to be close to, but pointing away from, each other. The following PCR cycling protocol was used: 94° for 5 min, (94° for 20 sec, 55° for 10 sec and 68° for 1 min/kb) repeated 34 times, and with a final extension time of 10 min at 68°. The inverse PCR fragments were gel-purified and further characterized. Some were used to create restriction maps to ascertain which inverse PCR products covered the largest portions of the uncharacterized genome sequence, while others were sequenced directly.

Verification of an 88 bp intron in ABC11 {#s7}
----------------------------------------

The *ABC11* intron was verified experimentally by amplifying the *ABC11* cDNA ORF from total RNA isolated from B2399 cells grown in YPD medium and harvested at late logarithmic growth. First strand *ABC11* cDNA was amplified from total RNA with SuperscriptIII Reverse Transcriptase (Invitrogen New Zealand, Auckland, NZ), and the *ABC11*-specific primer ABC11-Stop. A portion of this reaction was then used as DNA-template to PCR-amplify the entire *ABC11* cDNA ORF, and DNA sequencing confirmed the 88 bp intron.

Yeast strains overexpressing individual ABC1 and ABC11 alleles with or without an intron {#s8}
----------------------------------------------------------------------------------------

In order to compare the function of *C. krusei* Abc11p with Abc1p and Abc12p, the proteins were overexpressed in *S. cerevisiae* AD∆. The construction of *ABC1* overexpressing yeast strains AD∆/CkABC1g and AD∆/CkABC1c was described previously ([@bib40]. Because *ABC1* was toxic to *E. coli*, and it was impossible to clone and propagate plasmid pABC3-CkABC1 in *E. coli*, an alternative cloning strategy was developed ([@bib40]. However, this strategy required multiple PCR steps (\>60 PCR cycles) to amplify the entire transformation cassette (see top of [Figure S2](http://www.genetics.org/highwire/filestream/436283/field_highwire_adjunct_files/4/FigureS2.pdf)), which caused a high mutation rate. We therefore developed a new cloning strategy that is fast, highly reliable, and accurate, and could also be useful for cloning and sequencing individual alleles of other large genes. Rather than using multiple PCR steps to create the entire transformation cassette in one piece, we directly transformed AD∆ with separate PCR fragments that overlapped by 25 bp (center and bottom of [Figure S2](http://www.genetics.org/highwire/filestream/436283/field_highwire_adjunct_files/4/FigureS2.pdf)), and let the individual pieces fuse by homologous recombination. This required four or five separate homologous recombination events, which are exceptionally accurate and efficient in *S. cerevisiae*. Instead of using the *ABC11*-cDNA from the above experiment to create AD∆/CkABC11c, *ABC11c* was PCR-amplified from gDNA as two separate DNA fragments that overlapped by 25 bp, with the intron eliminated by primer design (see [Figure S2](http://www.genetics.org/highwire/filestream/436283/field_highwire_adjunct_files/4/FigureS2.pdf)). Equimolar amounts (total amounts were ∼0.6--1.2 µg) of these three or four (see center and bottom of [Figure S2](http://www.genetics.org/highwire/filestream/436283/field_highwire_adjunct_files/4/FigureS2.pdf)), gel-purified, PCR fragments were used to transform AD∆. All Ura^+^ transformants (∼10--30) were confirmed by colony PCR, and \>80% had the correct DNA sequence. The transformation rate using either three or four separate overlapping PCR fragments was only ∼5--10 times lower than the rates achieved for transformation with a single cassette.

Identification of individual alleles of the entire ABC11-ABC1 locus of C. krusei 89021, V2b, 90147, and 89221 {#s9}
-------------------------------------------------------------------------------------------------------------

To ascertain which allele of *ABC11* of strain 89021 was adjacent to which allele of *ABC1*, the 1.3 kb *Xho*I/*Bgl*II fragment (see [Figure S1B](http://www.genetics.org/highwire/filestream/436283/field_highwire_adjunct_files/0/FigureS1.pdf)) was subcloned, and six individual clones were sequenced. gDNA sequences for the *ABC11-ABC1* locus and sequences of individual *ABC1* alleles for V2b, 90147 and 89221 were also determined.

Functional analysis of wild-type and recombinant yeast strains {#s10}
--------------------------------------------------------------

The susceptibility of yeast to antifungal agents was measured by a microdilution assay as described previously ([@bib56]; [@bib27]). Agarose diffusion assays were performed to test the susceptibility of *S. cerevisiae* strains overexpressing *C. krusei* Abc1p or Abc11p to different xenobiotics. In brief, a 10 ml YPD overnight culture of each test strain was diluted 1:20 into 3 ml CSM medium, and grown at 30° for another 4 h to mid-logarithmic growth phase (OD~600~ ∼1; ∼10^7^ cells/ml). The cells were diluted to OD~600~ = 0.008 in 5 ml of molten CSM medium containing 0.6% agarose (45°), and overlaid on 20 ml CSM agar base medium. Whatman 3MM paper disks (5 mm diameter) containing xenobiotics were placed onto the solidified top agarose medium, and the plates were incubated at 30° for 48 h, or until growth inhibitory zones became clearly visible. The amounts of xenobiotics used are shown in the figure legends.

Chemosensitization assays {#s11}
-------------------------

The chemosensitization of yeast strains overexpressing *C. krusei* Abc11p or Abc1p to FLC was carried out as described previously ([@bib56]. In brief, cells were cultured in CSM medium as for agarose diffusion assays. Each test strain was diluted to OD~600~ = 0.008 in 10 ml of molten CSM containing 0.6% agarose (45°) with either no FLC (control to determine the toxicity of each drug) or FLC at 0.13× the MIC of FLC (MIC~FLC~). The cell suspension was poured into a rectangular Omnitray plate (126 × 86 × 19 mm; Nunc, Roskilde, Denmark) that contained 20 ml of CSM solidified with 0.6% agarose either without (control), or with FLC. Whatman 3MM paper disks containing potential drug pump inhibitors (1 µg of milbemycins α11, α20, β9, and β11, 0.2 µg ENI, 1 µg beauvericin, 5 µg FK506, and 25 nmol OLI) were placed on the overlay, and the plates were incubated at 30° for 48 h.

Analysis of phylogenetic relationships and identification of potential yeast transcription factor binding sites (TFBS) {#s12}
----------------------------------------------------------------------------------------------------------------------

Phylemon 2.0 ([@bib67]), a publicly available web-tool, was used for sequence alignments, tree reconstruction, and the estimation of synonymous and nonsynonymous distances. YeTFaSCo ([@bib15]), another web-tool, was used to search for potential yeast TFBSs upstream of *ABC1*, *ABC11*, and *ABC12*. Sequence alignments were performed with ClustalW v2.0.10 ([@bib72]) and viewed, and, if necessary, edited, with Jalview14.0 ([@bib77]). FigTree v1.4.0 (<http://tree.bio.ed.ac.uk/software/figtree/>) was used as a graphical viewer of phylogenetic trees and to produce publication-ready figures. Phylogenetic relationships were calculated by maximum likelihood analysis using PhyML v3.0 ([@bib23]; [@bib3]). Evolutionary tests for the synonymous and nonsynonymous substitution rates between pairs of genes were performed with CodeML and yn00 ([@bib81]) from PAML v4.4c ([@bib80]).

Helical wheel projections and determination of lipid facing surfaces (LIPS) of individual TMS {#s13}
---------------------------------------------------------------------------------------------

The surfaces of individual TMSs that most likely face the lipid bilayer were predicted with the LIPS server (<http://tanto.bioengr.uic.edu/lips/>; [@bib1]) using the sequences of the TMSs of 42 cluster A PDR transporters as input \[a list of these transporters and their alignment, with the predicted TMS boundaries highlighted, can be found in [@bib42])\]. The helical wheel projections of individual TMSs were created online (<http://rzlab.ucr.edu/scripts/wheel/wheel.cgi>).

GenBank accession numbers {#s14}
-------------------------

*ABC11* and *ABC1* sequences: 16.4 kb *ABC11-ABC1* gDNA of 89021 (JX679710); 13.9 kb of the *ABC11-ABC1* gDNA of 89221 (JX679711) and 90147 (JX679712); 7.7 kb *ABC11*, including 3.1 kb upstream, gDNA of V2b (JX679713) and 4.9 kb *ABC1*, including ∼100 bp upstream and downstream, gDNA of V2b (JX679714); 10 kb *ABC11-ABC1* locus (from *ABC11* start to *ABC1* stop) of the A allele (FJ445766) and the B allele (FJ445767) of 89021; 10 kb *ABC11-ABC1* locus of IFO0011 (KT716056) and B2399 (KT716053); 15.3 kb *ABC11-ABC1-11-chimera1-ABC1* locus of 89102 (KT716058) and 15.3 kb *ABC11-ABC1-11-chimera2-ABC1* locus of 89102 (KT716059); 5.3 or 4.9 kb *ABC1* A and B alleles (including the promoter and terminator) of 89221, 90147, and V2b (FJ445760-5); 6.3 kb *Hin*dIII/*Bam*HI fragment and *ABC1* cDNA of B2399 \[DQ903906-7 ([@bib41])\]; 4654 bp *ABC11-1 chimera* of IFO0011 (KT716057), *ABC11-1 chimera1* (KT716054) and *ABC11-1 chimera2* (KT716055) of B2399, and *ABC11-1 chimera* of 89102 (KT716060). *ERG11* sequences: *ERG11* A (FJ445752) and *ERG11* B (FJ445753) alleles of 89102.

Data availability {#s15}
-----------------

Strains are available upon request. Sequence data are available at GenBank and the accession numbers are listed above in the *Materials and Methods* section. [File S1](http://www.genetics.org/highwire/filestream/436283/field_highwire_adjunct_files/12/FileS1.pdf) contains Tables S1--S4, and detailed descriptions of all Supplemental Material (*i.e.*, legends for [Figure S1](http://www.genetics.org/highwire/filestream/436283/field_highwire_adjunct_files/0/FigureS1.pdf), [Figure S2](http://www.genetics.org/highwire/filestream/436283/field_highwire_adjunct_files/4/FigureS2.pdf), [Figure S3](http://www.genetics.org/highwire/filestream/436283/field_highwire_adjunct_files/5/FigureS3.pdf), [Figure S4](http://www.genetics.org/highwire/filestream/436283/field_highwire_adjunct_files/6/FigureS4.pdf), [Figure S5](http://www.genetics.org/highwire/filestream/436283/field_highwire_adjunct_files/7/FigureS5.pdf), [Figure S6](http://www.genetics.org/highwire/filestream/436283/field_highwire_adjunct_files/8/FigureS6.pdf), [Figure S7](http://www.genetics.org/highwire/filestream/436283/field_highwire_adjunct_files/9/FigureS7.pdf), [Figure S8](http://www.genetics.org/highwire/filestream/436283/field_highwire_adjunct_files/10/FigureS8.pdf), [Figure S9](http://www.genetics.org/highwire/filestream/436283/field_highwire_adjunct_files/11/FigureS9.pdf), [Figure S10](http://www.genetics.org/highwire/filestream/436283/field_highwire_adjunct_files/1/FigureS10.pdf), [Figure S11](http://www.genetics.org/highwire/filestream/436283/field_highwire_adjunct_files/2/FigureS11.pdf), and [Figure S12](http://www.genetics.org/highwire/filestream/436283/field_highwire_adjunct_files/3/FigureS12.pdf)).

Results {#s16}
=======

Characterization of a representative set of C. krusei isolates {#s17}
--------------------------------------------------------------

Although *C. krusei*, also known as *Issatchenkia orientalis* or *Pichia kudriavzevii*, is a relatively poorly studied ascomycetous yeast, it is important for natural food fermentation ([@bib10]), especially of cocoa beans for chocolate production. It is also an opportunistic fungal pathogen of humans that has reduced susceptibility to azole antifungals due, in part, to pump-mediated drug efflux ([@bib41]). Odds and colleagues developed a MLST database for clinical *C. krusei* isolates from all parts of the world ([@bib32]). Their data indicated that *C. krusei* is diploid (there was no mention of aneuploid or triploid strains), and there was no geographical association for particular subtypes. The high proportion (77%) of singletons (*i.e.*, unique diploid sequence types; DSTs), despite almost saturated levels of haplotypes, was taken as a sign that sexual recombination may play an important part in the *C. krusei* life cycle ([@bib32]).

The seven isolates used in the present study comprise a diverse range of isolates from humans, animals, and the environment; isolates from three different continents, different body sites, and different years of isolation (see Table S1 in [File S1](http://www.genetics.org/highwire/filestream/436283/field_highwire_adjunct_files/12/FileS1.pdf)). MLST confirmed that strain 89021 was closely related to 90147 and V2b, and, to a lesser extent, 89221, whereas the genotypes of 89102, IFO0011, and B2399 were somewhat different (see Table S3 in [File S1](http://www.genetics.org/highwire/filestream/436283/field_highwire_adjunct_files/12/FileS1.pdf)). As expected from Odds and colleagues' study ([@bib32]), only six (out of 42; ∼14%) new haplotypes were identified, yet six of the seven isolates (∼86%) had unique DSTs (see Table S3 in [File S1](http://www.genetics.org/highwire/filestream/436283/field_highwire_adjunct_files/12/FileS1.pdf)). Interestingly, New Zealand isolate 90147 had a DST (63) that was identical to an isolate from Italy (see Table S3 in [File S1](http://www.genetics.org/highwire/filestream/436283/field_highwire_adjunct_files/12/FileS1.pdf)). The peak height ratios of single nucleotide polymorphisms (SNPs) from sequencing chromatograms easily distinguished a diallelic (1:1 ratio) from a triallelic (1:2 ratio) sequence. All SNPs of 89021, 89221, 90147, V2b and IFO0011 had 1:1 peak ratios. However, all B2399 SNPs had 1:2 peak ratios, whereas 89102 exhibited 1:2 peak ratios for *ERG11* and *ABC1*, but 1:1 peak ratios for all housekeeping genes (see Table S4 in [File S1](http://www.genetics.org/highwire/filestream/436283/field_highwire_adjunct_files/12/FileS1.pdf)). This implied that *C. krusei* B2399 was triploid, 89102 was aneuploid with a trisomy in the *ERG11*- and *ABC1*-containing chromosome, and 89021, 89221, 90147, V2b, and IFO0011 were diploid, which was confirmed by measuring the fluorescence of cells stained with the DNA intercalating agent SYBR green (see [Figure S3](http://www.genetics.org/highwire/filestream/436283/field_highwire_adjunct_files/5/FigureS3.pdf)).

Discovery of the tandem-duplicated multidrug efflux transporter pair ABC11-ABC1 of C. krusei 89021 {#s18}
--------------------------------------------------------------------------------------------------

We previously characterized 6.3 kb (between the dashed vertical arrows; [Figure 1A](#fig1){ref-type="fig"}) of *C. krusei* B2399 gDNA containing the major multidrug efflux pump *ABC1* ([@bib41]). Overexpression of Abc1p in *S. cerevisiae* AD∆ caused multidrug resistance that could be reversed with known efflux pump inhibitors ([@bib40], [@bib41]). But, although *C. krusei* B2399 was triploid, averaging one SNP/400 nt for the ∼10 kb *ERG11* locus ([@bib41]), *ABC1* of *C. krusei* B2399 had no detectable SNPs ([@bib41]). Southern blot results for *C. krusei* B2399 gDNA, however, gave two unexpected *Eco*RI bands, indicating allelic variation or a recent tandem-duplication of *ABC1* ([@bib41]). This led ultimately to the discovery of the tandem-duplicated *ABC11-ABC1* locus of *C. krusei* 89021 ([Figure 1A](#fig1){ref-type="fig"}). Both ends of the 16.4 kb sequence contained partial ORFs (996 and 973 bp, respectively) of unknown function, and an additional 1512 bp ORF with high homology to the MATE (Multidrug And Toxic compound Extrusion) family of drug/sodium antiporters ∼2 kb upstream of *ABC11* ([Figure 1A](#fig1){ref-type="fig"}). *ABC11* and *ABC1* of 89021 had 19 and 16 SNPs, respectively (*i.e.*, an average SNP frequency of one SNP/532 nt; [Figure 1B](#fig1){ref-type="fig"}). The SNP frequency for the noncoding regions was ∼2.3 times higher (one SNP/244 nt), similar to the previously reported ∼threefold difference between coding and noncoding regions for the 10 kb *ERG11* locus of B2399 ([@bib41]). The average SNP frequency of one SNP/437 nt for the entire 16.4 kb was comparable with diploid *Candida* CTG clade pathogens such as *C. albicans* (one SNP/330--390 nt) or *C. tropicalis* (one SNP/576 nt; ([@bib8])). Interestingly, *ABC1* and *ABC11* also shared one identical intron (gray box; [Figure 1A](#fig1){ref-type="fig"}).

![Discovery of the tandem-duplicated multidrug efflux pump pair *ABC11-ABC1*, and polymorphism data for the *ABC11* and *ABC1* alleles of *C. krusei* 89021. *ABC11* and *ABC1* gene sequences are blue and green, respectively, and short and tall vertical lines are synonymous (sSNPs) and non-synonymous SNPs (nSNPs) between the alleles of each gene, respectively. The two vertical dashed arrows in (A) indicate previously characterized sequence ([@bib41]). (A) The 16.4 kb locus surrounding the *C. krusei* 89021 tandem-duplicated gene-pair *ABC11-ABC1*. ORFs and their orientation are indicated; gray boxes within *ABC1* and *ABC11* represent the common 88 bp intron. (B) A SNP map of *ABC11* and *ABC1* for the two chromosomes (Chr) of the diploid *C. krusei* 89021. Allelic differences between the ORF sequences are shown as magenta (Chr A) and purple (Chr B) SNPs, respectively. The map underneath shows the polymorphism pattern for the diploid sequence with red SNPs indicating polymorphisms that are the same in both *ABC11* and *ABC1* and black SNPs representing unique polymorphisms.](1619fig1){#fig1}

Sequence identity interspersed by four short stretches of sequence divergence distinguishes ABC1 from ABC11 {#s19}
-----------------------------------------------------------------------------------------------------------

We determined the sequences of 22 *ABC1* and *ABC11* alleles for the seven *C. krusei* strains ([Figure 2](#fig2){ref-type="fig"}) in order to identify the minimum (core) differences between *ABC1* and *ABC11*. Strains B2399, IFO0011 and strain 89102 had only one *ABC11* and one *ABC1* allele each ([Figure 2B](#fig2){ref-type="fig"}). However, the remaining four diploid *C. krusei* strains 89021, V2b, 90147, and 89221 each had two *ABC1* and two *ABC11* alleles ([Figure 2A](#fig2){ref-type="fig"}). In fact, all their *ABC11*-A, *ABC1*-A, and *ABC1*-B alleles were identical, apart from 89221 *ABC1*-B, which had one additional synonymous SNP (sSNP) in patch I ([Figure 2A](#fig2){ref-type="fig"}), and strain 89221, which had the two SNPs immediately upstream of patch II of *ABC11*-A on Chr A homogenized with *ABC1* sequence by a very recent EGC event (black arrow; [Figure 2A](#fig2){ref-type="fig"}). In contrast, the four *ABC11*-B alleles differed slightly from each other ([Figure 2A](#fig2){ref-type="fig"}). Overall, there were 92 core nucleotide differences (plus one extra codon near the stop codon of *ABC11*; see [Figure S4](http://www.genetics.org/highwire/filestream/436283/field_highwire_adjunct_files/6/FigureS4.pdf)) between *ABC11* and *ABC1* limited to six short (415 nt or 8.9% of the ORF) DNA stretches I--VI colored blue and green, respectively, in [Figure 2](#fig2){ref-type="fig"}. The five "fixed" SNP differences (blue and green SNPs; [Figure 2](#fig2){ref-type="fig"}) in both *ABC11* and *ABC1* near patches II, IV, and VI found in most strains were excluded from the core differences because they were homogenized by four EGCs in strains 89221, IFO0011 and B2399, respectively (all in the direction from *ABC1* to *ABC11*; black arrows in [Figure 2](#fig2){ref-type="fig"}). The six DNA patches I--VI that encoded the core differences between *ABC11* and *ABC1* were conserved in all but one of the 22 *ABC11* and *ABC1* alleles, with *ABC11* of strain 89102 having adopted *ABC1*-specific patches III and V by two separate EGCs from the neighboring *ABC1* allele ([Figure 2B](#fig2){ref-type="fig"}). It would appear that *ABC11* patches III and V are possibly less important for the biologically preserved Abc11p function.

![Sequence comparisons of *ABC11* with physically linked *ABC1* alleles of seven *C. krusei* strains. Within ORFs, the thick blue and green vertical lines represent the core sequence differences between *ABC11* (blue) and *ABC1* (green) found in all *ABC11* and *ABC1* alleles (*i.e.*, patches I--VI), while the thin blue and green lines outside these patches are SNPs that are found in almost all *ABC11* (blue) or *ABC1* (green) alleles. Orange SNPs represent SNPs unique to either *ABC11* or *ABC1* found in that particular allele. (A) Sequence differences between physically linked *ABC11* and *ABC1* alleles of Chr A and Chr B of the diploid *C. krusei* strains 89021, V2b, 89221 and 90147 are shown in the top and bottom panels, respectively. One EGC that homogenized sequences between patches I--II of Chr A of 89221 in the direction *ABC1* to *ABC11* (black arrows) is illustrated. This caused the loss of two blue "fixed" SNPs immediately upstream of *ABC11* patch II. (B) Map of sequence differences between physically linked *ABC11* and *ABC1* alleles of *C. krusei* B2399, IFO0011 and 89102; 89102 contained additional *ABC1-11* chimeras between *ABC11* and *ABC1* ([Figure 4A](#fig4){ref-type="fig"}). Five EGCs homogenized sequences between patches IV--V (B2399 and IFO0011), V--VI (IFO0011), and they converted patches III (89102) and V (89102) of *ABC11* to *ABC1* in 89102. They were all in the direction *ABC1* to *ABC11* (black arrows).](1619fig2){#fig2}

ABC1 and ABC11 are under very strong purifying selection and have evolved by concerted evolution for ∼134 MY {#s20}
------------------------------------------------------------------------------------------------------------

The vast majority of SNPs between individual alleles of *ABC1* and of *ABC11* were synonymous. Strain 89021, for example, had 16 *ABC1* and 19 *ABC11* SNPs, 15 and 16 of which were sSNPs, respectively (short vertical lines; [Figure 1B](#fig1){ref-type="fig"}). The nonsynonymous to synonymous nucleotide substitution ratio dN/dS (ω) of 0.052 for *ABC1* and 0.053 for *ABC11* of 89021 indicated that both genes were under very strong purifying selection. Even the ω value for the concatenated 252 nt of patches II--IV was not much higher (0.101; [Table 1](#t1){ref-type="table"}), suggesting that Abc1p and Abc11p subfunctionalized rather rapidly after duplication, and have since been under very strong purifying selection. The ω value for the concatenated 159 nt of patches I and VI, encoding the N- and C-termini, respectively, was much higher (0.347), suggesting that these 53 aa were of little functional consequence and, thus, under reduced purifying selection. *ABC11* was 97.8% identical to *ABC1*, with a calculated dS of 0.05 for the entire ORF, suggesting a rather recent duplication event ∼3.2 MYA ([Table 1](#t1){ref-type="table"}). However, dS within "protected" patches II--IV was much higher (1.18; [Table 1](#t1){ref-type="table"}), indicating that the duplicates were possibly much older (∼71 MY; [Table 1](#t1){ref-type="table"}).

###### Silent-site nucleotide substitution rates dS of *C. krusei* 89021 and *P. membranifaciens ABC1*, *ABC11*, and *ABC12*, and estimated times of duplication

  Sequences Compared       NBDs-TMDs   Patches II--IV   T[*^a^*](#t1n1){ref-type="table-fn"} (MY)                           
  ------------------------ ----------- ---------------- ------------------------------------------- ------- ------- ------- ---------------------------------------
  *CkABC1* - *CkABC11*     0.05        0.009            0.191                                       ---     ---     ---     3.2
                           ---         ---              ---                                         1.18    0.119   0.101   71
  *PmfABC1* - *PmfABC11*   0.41        0.061            0.150                                       ---     ---     ---     26
                           0.75        0.104            0.139                                       ---     ---     ---     46[*^b^*](#t1n2){ref-type="table-fn"}
                           0.15        0.017            0.116                                       ---     ---     ---     10[*^c^*](#t1n3){ref-type="table-fn"}
  *CkABC1 - PmfABC1*       2.13        0.114            0.054                                       ---     ---     ---     137
  *CkABC11 - PmfABC11*     2.01        0.121            0.060                                       ---     ---     ---     130
  *CkABC1 - CkABC12*       2.42        0.168            0.069                                       ---     ---     ---     156
  *PmABC1 - CkABC12*       2.30        0.184            0.080                                       ---     ---     ---     148
  *CkABC11 - CkABC12*      2.48        0.172            0.070                                       ---     ---     ---     160
  *PmABC11 - CkABC12*      2.03        0.183            0.090                                       ---     ---     ---     131
  *ScPDR5* - *ScPDR15*     1.55        0.152            0.098                                       ---     ---     ---     100
  ---                      ---         ---              1.67                                        0.073   0.044   100     

Estimated time since duplication or speciation (when comparing ORFs of *C. krusei* with *P. membranifaciens*). *ScPDR5* and *ScPDR15* are ohnologs of a whole genome duplication event ∼100 MYA ([@bib79]; [@bib34]). The times of retrotransposition of *CkABC12* (∼149 MYA; *i.e.*, from between 131 to 156 MYA), and duplication of *C. krusei* and *P. membranifaciens ABC1*/*11* (∼134 MYA; *i.e.*, from between 130 to 137 MYA) from their respective ancestors was estimated by comparing the silent-site substitution rates dS for the concatenated sequences of the conserved regions encoding NBD1-TMD1, NBD2-TMD2, or both NBDs and TMDs (NBDs-TMDs; the concatenated sequences included regions encoding amino acids Q99-E823 and N847-S1437 of *CkABC1* and *CkABC11*, amino acids D89-E813 and D848-M1433 of *PmfABC1*, and E95-E819 and D854-M1439 *PmfABC11*, E61-Q785 and S811-S1401 of *CkABC12*, D92-F808 and I868-K1503 of *ScPDR5* and N102-F818 and I883-K1518 of *ScPDR15*) of the indicated ORFs, and dS for the sequences encoded by patches II--IV of *CkABC1*/*CkABC11* (1.18) with those of *ScPDR5*/*ScPDR15* (*i.e.*, 1.55 and 1.67, respectively), assuming *S. cerevisiae*, *C. krusei*, and *P. membranifaciens* genes experience a similar dS/gene/MY.

Compare conserved NBD1-TMD1 sequences.

Compare conserved NBD2-TMD2 sequences.

This rather high estimate of ∼71 MY for a 97.8% identical tandem-duplicated pair of paralogs had to be further revised with the discovery of the *P. membranifaciens ABC11-ABC1* tandem-duplicate. The synteny of the *ABC11-ABC1* locus between *C. krusei* and *P. membranifaciens* was well conserved, which strongly suggested common ancestry ([Figure 3A](#fig3){ref-type="fig"}). The *P. membranifaciens* ORFs were also closely linked (separated by just 548 nt), and PmfAbc1p and PmfAbc11p each were 79% identical, and 87 and 89% homologous to CkAbc1p and CkAbc11p, respectively. Sequence comparison of *PmfABC1* (391367--395992 of scaffold2-contig42) with *PmfABC11* (386144--390818 of scaffold2-contig42; [Figure 3B](#fig3){ref-type="fig"}) clearly showed how parts of these two paralogs are, like *C. krusei ABC1* and *ABC11*, still evolving by concerted evolution, but in a different fashion (cf. [Figure 3, B and C](#fig3){ref-type="fig"}). *PmfABC1* and *PmfABC11* had a few shorter identical sequence patches in regions encoding the less conserved nucleotide-binding domain 1 (NBD1), there were no patches of sequence identity in ∼1/4 of the ORF encoding transmembrane domain 1 (TMD1), but alignments of the 3′ halves of *PmfABC1* with *PmfABC11* encoding the highly conserved NBD2 and the TMD2 regions showed a somewhat similar pattern to *CkABC1/CkABC11* ([Figure 3, B and C](#fig3){ref-type="fig"}). As with *C. krusei*, the estimated age for this pair of paralogs varied dramatically depending on which dS values were used for the calculations. Using dS for the entire ORF (0.41) gave an estimated age of 26 MY, the dS for the C-terminal half (0.15) gave an even lower estimate of ∼10 MY, but dS for the N-terminal half (0.75), which has almost completely escaped concerted evolution, gave an age of 46 MY ([Table 1](#t1){ref-type="table"}). The most accurate age-estimate for the duplication event of this pair of paralogs was obtained, however, when we compared the two pairs of orthologs with each other ([Figure 3, D and E](#fig3){ref-type="fig"}), because they had evolved independently from each other after speciation. There was surprisingly low (∼76%) sequence homology across the entire ORF ([Figure 3, D and E](#fig3){ref-type="fig"}) reflected in surprisingly high dS values for the *ABC1* (2.13) and *ABC11* (2.01) orthologs, providing an average age estimate of 134 MY since speciation ([Table 1](#t1){ref-type="table"}).

![Physical maps of the *ABC11-ABC1* loci of *C. krusei* and *P. membranifaciens*, and sequence comparisons between the two pairs of paralogs and orthologs. (A) Physical maps of the *ABC11-ABC1* loci of *C. krusei* (top) and *P. membranifaciens* (bottom). ORFs are named according to orthology with the *S. cerevisiae* genome database (SGD) where possible. Assembly of the *C. krusei ABC11-ABC1* consensus is described in [Figure S7](http://www.genetics.org/highwire/filestream/436283/field_highwire_adjunct_files/9/FigureS7.pdf). The *P. membranifaciens ABC11-ABC1* locus was contained in the ∼459 kb scaffold2-contig42 (from 372000 to 404000). Synteny between *C. krusei* and *P. membranifaciens* was remarkably well preserved. Numbers within the *C. krusei* ORFs show their % GC3 content (see text for further details). (B--D) Representations of sequence alignments between indicated ORFs. Regions of identity are in blue and individual nucleotide differences are shown as vertical white lines. Light blue regions are gaps in the alignment. Each lane is 140 nt long. The alignments in (B and C) demonstrate how the *ABC11-ABC1* paralogs of *P. membranifaciens* and *C. krusei* both are still experiencing concerted evolution with regions of sequence identity interspersed by regions of sequence divergence that are protected from EGCs by strong purifying selection. However, the sequence comparisons between the "orthologs" of *C. krusei* and *P. membranifaciens* \[*i.e.*, *CkABC1* with *PmfABC1* (D) and *CkABC11* with *PmfABC11* (E)\] show that these orthologs are actually much older (∼134 MY; [Table 1](#t1){ref-type="table"}), exhibiting limited sequence identity (∼75%) randomly distributed across their entire ORFs.](1619fig3){#fig3}

Thus, we conclude that the majority of *C. krusei ABC1* and *ABC11* evolved by concerted evolution for possibly \>134 MY; however, patches II--V of *C. krusei ABC11--ABC1* were strongly protected against frequent EGCs for ∼70 MY in order to preserve important functional differences between the two gene products. This hypothesis was supported by the fact that the majority of SNPs between patches I--VI of *ABC1* and *ABC11* were shared polymorphisms (10 red SNPs; [Figure 1B](#fig1){ref-type="fig"})---a characteristic feature for the concerted evolution of duplicated genes ([@bib29]; [@bib59]; [@bib4]).

Intramolecular and intermolecular (non)homologous recombination events caused gene deletions and CNVs, and generated a number of ABC11-1 chimeras {#s21}
-------------------------------------------------------------------------------------------------------------------------------------------------

The chromosomal arrangements for *ABC1* and *ABC11* of B2399, IFO0011 and 89102 were difficult to unravel because of apparent CNVs. After careful consideration, we were able to successfully amplify, clone, sequence, and functionally express the "hidden" gene copies in *S. cerevisiae* AD∆. These copies comprised two *ABC1--11* and four *ABC11--1* chimeras ([Figure 4A](#fig4){ref-type="fig"}), which is why these "hidden" genes could not be PCR amplified with *ABC1*- or *ABC11*-specific primer pairs. *ABC11* and *ABC1* of IFO0011 and B2399 were very similar to the A alleles on Chr A of all other diploid strains ([Figure 2](#fig2){ref-type="fig"}). However, both strains had lost one gene copy each, probably via intramolecular homologous recombination between one of three different DNA stretches of sequence identities between *ABC11* and *ABC1* on IFO0011 ChrB and B2399 ChrA' and ChrB ([Figure 4, A and B](#fig4){ref-type="fig"}). This generated three different *ABC11-1* chimeras, either possessing the majority of the 10 shared A or the 10 shared B allele-specific SNPs of strain 89021 (see [Figure S5](http://www.genetics.org/highwire/filestream/436283/field_highwire_adjunct_files/7/FigureS5.pdf)), with all three *ABC11-1* chimeras being put under the control of the *ABC11* promoter ([Figure 4A](#fig4){ref-type="fig"}). A different, intermolecular, nonhomologous mitotic recombination event between patches I and II of *ABC1* on ChrA and *ABC11* on ChrB in the ancestor of 89102 ([Figure 4C](#fig4){ref-type="fig"}) is likely to have generated a single *ABC11-1* chimera on ChrA, and an additional *ABC1-11* chimera between *ABC11* and *ABC1* on ChrB ([Figure 4A](#fig4){ref-type="fig"}). A more detailed description of how 89102 possibly obtained its complex chromosomal arrangement since that initial intermolecular, nonhomologous, recombination event can be found in [Figure S6B](http://www.genetics.org/highwire/filestream/436283/field_highwire_adjunct_files/8/FigureS6.pdf).

![*C. krusei* IFO0011, B2399, and 89102 possess copy number variations (CNVs) for *ABC1* and *ABC11*. (A) Chromosomal arrangement of *ABC1* and *ABC11* alleles found in *C. krusei* 89021 (the same arrangement was found in *C. krusei* 89221, 90147 and V2b), IFO0011, B2399, and 89102. (B) Three separate gene deletions caused by intramolecular homologous recombination between homogenized DNA tracts 1, 2, and 3 of *ABC11* and *ABC1* can explain the loss of gene copies and the resulting chimeric alleles found in three chromosomes of strains IFO0011 (Chr B) and B2399 (Chr A' and Chr B). (C) The ancestor of 89102 likely experienced an intermolecular nonhomologous mitotic recombination between patches I and II of *ABC1* on Chr A and *ABC11* on Chr B (a detailed evolutionary history of the unusual chromosomal arrangement of strain 89102 is proposed in [Figure S6B](http://www.genetics.org/highwire/filestream/436283/field_highwire_adjunct_files/8/FigureS6.pdf)).](1619fig4){#fig4}

The fact that all physically linked *ABC11* and *ABC1* ORFs grouped into either A or B allele types (see [Figure S6C](http://www.genetics.org/highwire/filestream/436283/field_highwire_adjunct_files/8/FigureS6.pdf)) clearly demonstrated that intermolecular meiotic crossovers and allelic gene conversions between neighboring copies of the ∼10 kb *ABC11-ABC1* locus were much rarer than EGCs; otherwise, we would not have found such clear demarcations of almost exclusively shared (red) or allele-specific (black; [Figure 1B](#fig1){ref-type="fig"}) SNPs between individual tracts of sequence divergence, and, most importantly, we would have expected a significant reduction in the SNP frequency in parts that had experienced a recent allelic gene conversion, which clearly was not the case---random SNP distribution between individual alleles of *ABC11* and *ABC1* is evident in [Figure 1B](#fig1){ref-type="fig"}.

First direct estimates for the gene conversion rate and the size of the MEPS {#s22}
----------------------------------------------------------------------------

Polymorphism-based methods can overcome the methodological limitations that preclude precise estimates for the rate of EGC ([@bib4]). Therefore, we exploited the sequence information we had collected from a sample of strains representative for the *C. krusei* population to obtain the first "direct," empirical, estimates for the gene conversion rate without relying on computer modeling.

The polymorphism patterns in [Figure 1B](#fig1){ref-type="fig"} suggested that ten recent EGCs ([Figure 5A](#fig5){ref-type="fig"}) between individual patches of sequence divergence between physically linked *ABC11* and *ABC1* gene copies of *C. krusei* 89021 homogenized an entire tract in one event rather than in multiple smaller EGC events. This conclusion is based on the observation that tracts exposed to frequent EGCs between strongly protected patches of sequence divergence contained either almost exclusively shared polymorphisms or allele-specific SNPs randomly distributed across entire tracts ([Figure 1B](#fig1){ref-type="fig"}). If, for example, the most recent EGC homogenized only half a tract between *ABC11* and *ABC1*, then one half would be expected to contain shared polymorphisms only (red SNPs), and the other half a number of allele-specific SNPs (black SNPs), but that clearly was not the case. In addition, as mentioned above, there was also no noticeable interference with the observed polymorphism patterns by allelic gene conversions or meiotic crossover events.

![The ten most recent EGCs between patches I--VI of *C. krusei* 89021 *ABC11* and *ABC1* enable empirical estimates for important gene conversion parameters. (A) Ten separate recent EGCs, five (EGC 1--5) between "protected" patches I--VI of the A alleles and five (EGC 6--10) between "protected" patches I--VI of the B alleles of *ABC11* and *ABC1*, of unknown direction (black arrows), caused almost identical sequences for the majority of the two physically linked ORFs. (B) Relationship between the estimated average age of the five most recent EGCs between the six patches of core sequence differences of *ABC11* and *ABC1* of *C. krusei* 89021, and the tract length between these individual patches of sequence difference. (C) Relationship between the calculated gene conversion rate per gene per 100 MY and the tract length between these patches of sequence difference. MEPS = *x* when *y* = 0 (106 nt; arrow pointing to MEPS). (D) Percent GC content in codon position 3 (GC3) for 100 bp segments of *ABC1* (green) and *ABC11* (blue). Patches I--VI are indicated with vertical gray bars, and the average GC3 content within and between patches I--VI is indicated with horizontal gray and dotted lines, respectively.](1619fig5){#fig5}

Given the clarity of these results, we applied a molecular clock (assuming an estimated nucleotide substitution rate of 0.8 per silent-site per 100 MY for fungi ([@bib46]), and one, rather than multiple, gene conversions per tract) to estimate the age of these 10 most recent EGC events ([Table 2](#t2){ref-type="table"}). The age of the 10 most recent EGC events was calculated by counting the number of sSNPs that had accumulated between individual patches since the last EGC and calculating dS. However, these age estimates could be up to ∼8 times higher or ∼2 times lower, because the nucleotide substitution rates can range anywhere from ∼0.1 to ∼1.6 per silent-site per 100 MY in different organisms ([@bib46]). The paucity of new SNPs in EGC tracts reflects the higher rate of EGC than natural mutation. With these limitations in mind our best estimates for the average age of the four recent EGCs between the two largest tracts (1.2 and 1.7 kb; *i.e.*, EGCs 3 and 8 and EGCs 1 and 6; [Figure 5A](#fig5){ref-type="fig"}) were 0.43 and 0.13 MY, respectively, while the calculated average age for the three smaller tracts (339--399 bp; *i.e.*, EGCs 2 and 7, EGCs 4 and 9, and EGCs 5 and 10; [Figure 5A](#fig5){ref-type="fig"}) ranged from 0.53 to 1.68 MY ([Table 2](#t2){ref-type="table"}). Assuming a constant gene conversion rate, these equated to 30--385 gene conversions per gene per 100 MY ([Table 2](#t2){ref-type="table"}). Because all five tracts between the "protected" patches of sequence divergence of the two paralogs, *ABC1* and *ABC11*, were separated by the same distance (∼5.3 kb), there appeared to be little interference with EGC by allelic gene conversion, and, because the effect of genome location could be ignored (as all events occurred in the same location), we could tentatively investigate the influence of tract length on the EGC rate in *C. krusei*. Despite the limited number of EGC events there was an inverse correlation between the average age of the most recent EGC and its tract length ([Figure 5B](#fig5){ref-type="fig"}), and a direct linear correlation between the gene conversion rate and its tract length ([Figure 5C](#fig5){ref-type="fig"}). Extrapolating the graph in [Figure 5C](#fig5){ref-type="fig"} to *y* = 0 gave a direct estimate for the MEPS of 106 nt for duplicated loci separated by 5.3 kb in *C. krusei*.

###### Estimation of the gene conversion rate between patches of individual alleles of the *ABC11-ABC1* locus of *C. krusei* 89021

  DNA Between   Tract Length (bp)   N~S~[*^a^*](#t2n1){ref-type="table-fn"}   sSNPs   sSNPs   Y (10^−6^) Since Last Gene Conversion[*^c^*](#t2n3){ref-type="table-fn"}   Average Time Since Last Gene Conversion (MY)   Gene Conversion Rate/Gene/100 MY   
  ------------- ------------------- ----------------------------------------- ------- ------- -------------------------------------------------------------------------- ---------------------------------------------- ---------------------------------- -----
  I--II         1650                492                                       0       0       \<0.13                                                                     \<0.13                                         0.13                               385
  III--IV       1209                360                                       0       4       \<0.17                                                                     0.69                                           0.43                               116
  V--VI         399                 117                                       1       0       0.53                                                                       \<0.53                                         0.53                               94
  IV--V         375                 112                                       0       5       \<0.56                                                                     2.79                                           1.68                               30
  II--III       339                 93                                        1       0       0.67                                                                       \<0.67                                         0.67                               75

The 88 bp intron was removed for this analysis.

N~S~ is the calculated number of possible synonymous sites.

These are the numbers of sSNPs in the A or B alleles between individual patches of *ABC11* and *ABC1*.

The time since the last gene conversion event was calculated by using the synonymous nucleotide substitution rate (dS) as a molecular clock, assuming an estimated dS of 0.8 per synonymous site per 100 MY for fungi ([@bib46]) (N~S~ is twice the above listed value because one gene conversion event "homogenizes" the sequences of both paralogs, *ABC1* and *ABC11*).

Gene conversion in C. krusei shows GC-bias {#s23}
------------------------------------------

There is substantial evidence that frequent EGCs lead to increased GC-content, especially at the third positions in codons (GC3) that are under little selective constraint, due to GC-bias in mismatch repair ([@bib21]; [@bib57]). Others, however, have found little evidence for GC-bias due to mismatch repair, and argued that GC-content may favor EGC rather than EGC being GC-biased ([@bib9]; [@bib4]). The average GC3-content of those parts of *ABC1* and *ABC11* that were exposed to frequent EGCs was significantly higher (∼50%) than the GC3-content (∼35%) for patches I--VI that were strongly protected against frequent EGCs ([Figure 5D](#fig5){ref-type="fig"}). The GC3-content of patches I--VI was similar to the GC-content (38.3%) for the entire *C. krusei* M12 genome ([@bib10]), and, most importantly, the GC3-content of all neighboring genes ([Figure 3A](#fig3){ref-type="fig"}), and all *C. krusei* PDR transporters including *ABC12*, which shares a common ancestor with *ABC1* and *ABC11* (see below), were equally low (∼38%) (data not shown). Our data therefore favor a model of GC-bias of mismatch repair for EGC in *C. krusei*.

Elucidation of the ABC11-ABC1 locus {#s24}
-----------------------------------

*ABC1* and *ABC11* belong to cluster A of the nine clusters (A-H2) of fungal PDR transporters ([@bib42]). We searched recently released draft genome sequences of *C. krusei* M12 ([@bib10]), SD108 and NBRC 1279T, environmental isolates from Malaysia, the United States and Russia, respectively (see Table S1 in [File S1](http://www.genetics.org/highwire/filestream/436283/field_highwire_adjunct_files/12/FileS1.pdf)), for all possible PDR transporter homologs, and identified three cluster A (*ABC1*, *ABC11* and *ABC12*), six cluster D (two *S. cerevisiae* Pdr12p and four *S. cerevisiae* Snq2p homologs), and one cluster F member (data not shown). No *ABC1* or *ABC11* ORF sequences were found in NBRC 1279T, although contig 614 contained ∼9 kb DNA upstream of *ABC11*, and included *ABC11* patch I, and contig 294 contained ∼6 kb DNA downstream of *ABC1*, and included *ABC1* patch VI (see [Figure S7](http://www.genetics.org/highwire/filestream/436283/field_highwire_adjunct_files/9/FigureS7.pdf)). However, five M12 contigs and five SD108 scaffolds contained ∼50% of *ABC1* and *ABC11* including ∼14 kb (contig 327) and ∼113 kb (scaffold 21) of *ABC11* upstream DNA and ∼6 kb (contig 351) and ∼41 kb (scaffold 21) of *ABC1* downstream DNA (see [Figure S7](http://www.genetics.org/highwire/filestream/436283/field_highwire_adjunct_files/9/FigureS7.pdf)). SD108 scaffold 21, the longest contig (161 kb), contained a predicted *ABC11-1* chimera with an ∼600 bp N-terminal insertion following *ABC11* patch I (see [Figure S7](http://www.genetics.org/highwire/filestream/436283/field_highwire_adjunct_files/9/FigureS7.pdf)). Despite some unresolved regions of M12, the available *ABC1* and *ABC11* ORF sequences matched the A alleles of 89021 (100% identity), whereas the available SD108 sequences matched the B alleles, with only 8 nt differences to the B alleles of 89021, all of which were also detected in some B alleles of the other six *C. krusei* strains (data not shown). Scaffold 21 also contained the *C. krusei* azole drug target *ERG11* just 59.9 kb upstream of the *ABC11-1* chimera, confirming our observation that *ERG11*, *ABC1*, and *ABC11* are closely linked on the same chromosome.

Discovery of ABC12 {#s25}
------------------

We named the third cluster A PDR transporter discovered in another part of the *C. krusei* genome Abc12p, because it showed highest homology (84%) to Abc1p and Abc11p. All three recent *C. krusei* genome databases agreed on the chromosomal assembly for *ABC12* encoded on M12 contig 30, NBRC 1279T contig 223, and SD108 scaffold 33. *ABC12* of *C. krusei* M12 had only four or eight SNPs compared to *ABC12* of SD108 or NBRC 1279T, respectively, with just 1 aa difference in Abc12p between M12 and SD108 (H1424R) or NBRC 1279T (K781E). Interestingly, *P. membranifaciens* had only two cluster A PDR transporters, *PmfABC1* and *PmfABC11*, indicating it had lost its *ABC12* ortholog. Comparing a map for the *C. krusei ABC12* locus with a map of the same chromosomal region of *P. membranifaciens* ([Figure 6A](#fig6){ref-type="fig"}) indicated how *P. membranifaciens* may have lost *ABC12*. There was an inversion of ∼20 kb (gray; [Figure 6A](#fig6){ref-type="fig"}) immediately upstream of *C. krusei ABC12* (pink; [Figure 6A](#fig6){ref-type="fig"}), and *ABC12* may have been lost during this inversion event (*PmfABC12* is the only missing ORF at this locus; [Figure 6A](#fig6){ref-type="fig"}). Interestingly, three of the seven *C. krusei* strains (89021, 89221, and 90147) had only one intact copy of *ABC12*, with the second allele being an inactive pseudogene \[*i.e.*, a C2275T mutation caused Q759 (CAA codon) to become a TAA stop codon\].

![Physical maps of the *ABC12* loci of *C. krusei* and *P. membranifaciens*, and a topology map of aa differences between multidrug efflux pumps *C. krusei* Abc1p and Abc11p. (A) Physical maps of the *ABC12* loci of *C. krusei* (top) and *P. membranifaciens* (bottom). ORFs are named according to orthology with the *S. cerevisiae* genome database (SGD) where possible. The *C. krusei ABC12* assembly is a consensus between M12 contig 30 (*ABC12* = 56555--61015; Abc12p = 1486 aa), SD108 scaffold 33 (*ABC12* = 62859--67319) and NBRC 1279T contigs 223 (*ABC12* = 39451--43911) and 259 (3′ end from *DST1*). The *P. membranifaciens* locus was within the ∼153 kb scaffold2-contig136 contig (from 56000 to 87000). There was no *ABC12* homolog in *P. membranifaciens*. It appears that *P. membranifaciens* lost *ABC12* (pink ORF in *C. krusei*) during an inversion of the sequence (∼18 kb) highlighted in gray just upstream of *C. krusei ABC12*. (B) Maximum likelihood tree for *C. krusei* and *P. membranifaciens* Abc1p and Abc11p and *C. krusei* Abc12p and their phylogenetic relationship to the cluster A PDR transporters of representative species of the three major Saccharomycotina lineages: *Saccharomycetaceae* (green) species *S. cerevisiae* (Sc) and *C. glabrata* (Cg), *Candida* CTG (magenta) species *C. albicans* (Ca) and *Pichia stipitis* (Ps), and the third major Saccharomycotina lineage (blue) species *H. parapolymorpha* (Hp), *P. membranifaciens* and *C. krusei*. *Y. lipolytica* cluster B PDR transporter *YliQ6CET9* was used as the outgroup. The bootstrap support values of 100 replicates are shown above individual branches, and branches with 100% bootstrap support are marked with an asterisk. (C) Predicted topology of the Abc1p and Abc11p TMDs with the location of the 18 core aa differences within patches II, III, IV, and V highlighted. The gray background represents the membrane bilayer. Open boxes represent TMS1--12 (from left to right), with ELs and ILs connecting individual TMSs in yellow and blue, respectively. The regions corresponding to patches II--V are in gray boxes, and amino acids that differed between Abc1p and Abc11p of *C. krusei* B2399 are shown as circles. Sequence comparison with their common ancestor Abc12p revealed which differences between Abc1p and Abc11p were due to changes in Abc1p (two green circles), Abc11p (13 blue circles), or in both Abc1p and Abc11p (three red circles). Amino acids with thick circles are unique changes when compared with all other fungal cluster A PDR transporters.](1619fig6){#fig6}

C. krusei belongs to a recently discovered third major Saccharomycotina lineage {#s26}
-------------------------------------------------------------------------------

Although yeast comprise a broad phylogenetic range of species ([@bib38]), research within the large Saccharomycotina family has primarily focused on members of the Saccharomycetaceae and the *Candida* CTG lineages ([@bib73]; [@bib17]). This is why the third major Saccharomycotina lineage has only recently been discovered ([@bib52]; [@bib26]; [@bib64]). It includes the methylotrophic *Pichia pastoris* ([@bib16]) and *Hansenula polymorpha* ([@bib63]), the nitrate-assimilating yeasts *H. polymorpha* ([@bib63]), *Dekkera bruxellensis* ([@bib12]), and *Kuraishia capsulata* ([@bib52]), and also *C. krusei* and *P. membranifaciens* ([@bib64]). It is now clear that the Saccharomycetaceae lineage is the oldest branch, and the *Candida* CTG clade and the third major Saccharomycotina lineage separated later ([@bib52]; [@bib64]). A ClustalW-alignment of all cluster A PDR transporters of five *Candida* CTG, seven Saccharomycetaceae and two species (*H. polymorpha* and *C. krusei*) of the third Saccharomycotina lineage is shown in [Figure S8](http://www.genetics.org/highwire/filestream/436283/field_highwire_adjunct_files/10/FigureS8.pdf). Abc1p, Abc11p, and Abc12p, as well as *H. polymorpha* HpCdr2p and HpCdr4p, had two characteristic 3-aa deletions at the center of extracellular loop EL3 and the beginning of EL6 (see [Figure S8](http://www.genetics.org/highwire/filestream/436283/field_highwire_adjunct_files/10/FigureS8.pdf) and [Figure S9](http://www.genetics.org/highwire/filestream/436283/field_highwire_adjunct_files/11/FigureS9.pdf)). A maximum likelihood tree of all cluster A PDR transporters from two or three species of each of the three Saccharomycotina lineages matched their species tree ([@bib52]; [@bib64]) with good bootstrap support ([Figure 6B](#fig6){ref-type="fig"}). These findings confirmed that *C. krusei* and *P. membranifaciens* belong to a third, only recently discovered, major Saccharomycotina lineage.

Intron loss in ABC12 and deintronization in ABC1 and ABC11 {#s27}
----------------------------------------------------------

The ClustalW alignment of ABC sequences (see [Figure S8](http://www.genetics.org/highwire/filestream/436283/field_highwire_adjunct_files/10/FigureS8.pdf)) highlighted a 30-aa N-terminal insertion in *C. krusei* Abc1p and Abc11p, absent in all other homologs ([Figure 7A](#fig7){ref-type="fig"} shows an alignment of this region for *C. krusei* and *P. membranifaciens* Abc1p, Abc11p, and *C. krusei* Abc12p). We hypothesized that the common ancestor of *ABC1*, *ABC11*, and *ABC12* had at least two introns, which were lost in *ABC12* by retrotransposition into another part of the genome, while *ABC1* and *ABC11* converted (*i.e.*, deintronized) one intron into coding sequence, but kept the second intron intact. To test this hypothesis, we searched the DNA sequences encoding the 15--30 aa insertion in *ABC1* and *ABC11* for remnants of the conserved yeast splice site (ss) signals \[*i.e.*, 5′ ss, 3′ ss, and branch site (BS) signal; ([@bib37])\]. There was reasonable homology between *ABC1*/*ABC11* and *ABC12* before and after the predicted intron boundaries, particularly for *C. krusei ABC1* and *ABC11*, and splice site remnants were still visible ([Figure 7B](#fig7){ref-type="fig"}). The predicted 5′ ss GTACG was changed to [AC]{.ul}ACG, the BS TACTAAC was changed to T[T]{.ul}C[A]{.ul}AAC, and the potential 3′ ss TTNNTAG was changed to [A]{.ul}TNN[C]{.ul}AG in *C. krusei ABC1* and *ABC11* ([Figure 7B](#fig7){ref-type="fig"}). The two most significant changes, each of which would abolish splicing, are the GT to AC changes of the 5′ ss, and the T to A change of the BS. Deintronization of the inferred 92 bp intron may have caused a frameshift and a temporary pseudogene, which was possibly recovered by the inferred 10 bp insertion just 21 nt downstream ([Figure 7B](#fig7){ref-type="fig"}). Because all four Abc1p/Abc11p paralogs share this unusual insertion ([Figure 7A](#fig7){ref-type="fig"}), it would seem that, after the proposed initial deintronization event (possibly not long before speciation; ∼134 MYA) *P. membranifaciens ABC1* and *ABC11* responded quite differently to the functional disturbance caused by the ∼30-aa insertion; *PmfABC1* had a 45- and *PmfABC11* had an 18-nt deletion ([Figure 7B](#fig7){ref-type="fig"}). However, without a cluster A PDR transporter sequence that still contains this "ancient" intron, the proposed deintronization could have also been a random insertion event instead.

![Evidence for a possible deintronization event in the ancestor of *C. krusei* and *P. membranifaciens ABC1* and *ABC11*, and evidence for intron loss by retrotransposition in *C. krusei ABC12*. Identical sequences are highlighted in dark blue and residues that are \>80% conserved in (A) are in light blue. (A) Alignment of the N-termini of Abc1p, Abc11p, and Abc12p revealed a 30-aa insertion (the area highlighted in gray) in CkAbc1p and CkAbc11p, and slightly shorter 15 and 24 aa insertions in PmfAbc1p and PmfAbc11p, respectively. (B) Alignment of the DNA sequences encoding the amino acids boxed in (A). Remnants of the 5′ and 3′ splice site (ss; dark gray) and branch site (BS) signals (underlined) were clearly visible in *CkABC1* and *CkABC11*; *PmfABC1* and *PmfABC11* may have experienced further deletions (*i.e.*, 45 and 18 nt, respectively) in this region to accommodate the possibly detrimental functional effects of the initial deintronization event. Changes to the conserved ss signals in *CkABC1* and *CkABC11* are highlighted with bold-type letters underneath the alignment. Deintronization of the "ancient" 92 bp intron may have caused the formation of a pseudogene, the function of which was possibly recovered by the 10 bp insertion (marked in gray) just 21 nt downstream. (C) Sequence alignment of *C. krusei* and *P. membranifaciens ABC1* and *ABC11* with *C. krusei ABC12* surrounding the *ABC1*/*ABC11* intron \[the position in the protein where the intron is inserted is marked with an arrow in (A)\] confirmed the loss of this "ancient" intron in *ABC12*. Conserved 5′ ss, 3′ ss and BS signals are marked in dark gray (5′ and 3′ ss) or are underlined (BS). Concerted evolution kept identical 88 bp introns in *CkABC1* and *CkABC11*, but the 77 bp *PmfABC1* and the 109 bp *PmfABC11* introns escaped such concerted evolution. Not only are these two introns completely different in size and sequence, but each has also gained an additional 11 bp (*PmfABC1*) and 16 bp (*PmfABC11*) polypyrimidine tract (dark gray).](1619fig7){#fig7}

An alignment of *C. krusei* and *P. membranifaciens ABC1* and *ABC11* with *C. krusei ABC12*, inferred from protein alignments surrounding the confirmed 88 bp intron ([Figure 7A](#fig7){ref-type="fig"}), revealed conserved splice site signals and intron boundaries ([Figure 7C](#fig7){ref-type="fig"}), strongly supporting *ABC12* intron loss by retrotransposition. Interestingly, *PmfABC1* and *PmfABC11* introns had conserved splice site signals, but, unlike the 88 bp *CkABC1*/*11* intron, they were completely different from each other, both in sequence and length (78 bp *vs.* 109 bp; [Figure 7C](#fig7){ref-type="fig"}).

Functional characterization of Abc1p, Abc11p, and Abc12p {#s28}
--------------------------------------------------------

To investigate functional differences between Abc1p, Abc11p, and Abc12p, we overexpressed each in the host *S. cerevisiae* AD∆, a strain that is deleted in seven ABC pumps, and thus exquisitely sensitive to many xenobiotics, and which achieves exceptionally high expression of ABC proteins ([@bib40]). Both gDNA and cDNA ORFs encoding Abc1p and Abc11p of B2399 were cloned separately to see if the presence of introns affected the yeast phenotype. The presence of the intron did not alter drug resistance conferred by Abc1p or Abc11p significantly \[see [Figure S10](http://www.genetics.org/highwire/filestream/436283/field_highwire_adjunct_files/1/FigureS10.pdf) and [@bib41])\]. Strains overexpressing Abc1p or Abc11p were found to be resistant to a number of xenobiotics: *i.e.*, resistant to azole antifungals (FLC, CLT, ITC, MCZ, and VRZ), fluorescent substrates (R6G and R123), large ionophores (NIG), translation inhibitors (CHX and ANI), and anticancer drugs (DOX and DAU; see [Figure 8A](#fig8){ref-type="fig"} and [Figure S10](http://www.genetics.org/highwire/filestream/436283/field_highwire_adjunct_files/1/FigureS10.pdf)). The antifungal AUR and the antipsychotic drug TFP, however, were not substrates of either pump (see [Figure S10](http://www.genetics.org/highwire/filestream/436283/field_highwire_adjunct_files/1/FigureS10.pdf)). Abc12p had the same substrate specificities as Abc1p and Abc11p (the seven Abc1/11p substrates tested in [Figure 8A](#fig8){ref-type="fig"} were also Abc12p substrates). Although all three multidrug efflux-pumps transported the same range of substrates, their transport activities for individual compounds differed significantly ([Figure 8A](#fig8){ref-type="fig"}). Abc1p appeared to pump the selected test compounds best overall. However, Abc12p was the best transporter of the smaller test compounds \[*i.e.*, low molecular weight (MW); ANI, CHX, FLC, and CLT\], and Abc11p was the best transporter of the larger (*i.e.*, high MW) test compounds (R6G and NIG). Perhaps surprisingly, Abc11p of 89102 (pump strain A in [Figure 8A](#fig8){ref-type="fig"}), a chimera with two Abc1p-specific amino acids in TMS6 (patch III) and one in TMS11 (patch V), was an even better multidrug efflux pump (*i.e.*, it was more resistant to most test compounds) than Abc1p. Additional variations in substrate specificities were observed for the remaining *ABC11-1* and *ABC1-11* chimeras ([Figure 8A](#fig8){ref-type="fig"}, pump strains B--E and F--G, respectively). Although all chimeras were clearly functional, some effluxed certain compounds even more efficiently than wild-type Abc11p or Abc1p (*e.g.*, FLC efflux by Abc1-11p chimeras; [Figure 8A](#fig8){ref-type="fig"}, pump strains F and G) whereas some Abc11-1p chimeras showed severely reduced drug efflux, especially of ANI, KTC, or NIG ([Figure 8A](#fig8){ref-type="fig"}, pump strains B, C, and E).

![Substrate transport and inhibitor sensitivity profiles conferred by Abc1p, Abc11p, and Abc12p. (A) The drug susceptibilities of the sensitive control strain AD∆ (0.25, 0.015, 1, 0.002, 0.5, 0.008, and 0.25 mg/l for ANI, CHX, FLC, CLT, R6G, KTC, and NIG, respectively) were set to 1. The MWs of the seven test drugs are listed under their names. The bar charts for the seven individual test drugs show the fold-increased drug susceptibilities (note that the *y*-axis is logarithmic) of AD∆ strains overexpressing *C. krusei ABC11* (11; blue), *ABC1* (1; green), and *ABC12* (12; orange), and of AD∆ strains overexpressing all other chimera genes; *i.e.*, *ABC11* of strain 89102 (A; light blue); *ABC11-1* chimeras of B2399 (B and E), IFO0011 (C), and 89102 (D); and *ABC1-11* chimeras of 89102 (F and G). *ABC11-1* chimeras A--E are in different shades of blue, and *ABC1-11* chimeras F--G are in different shades of green. All ORFs contained the N-terminal intron and a C-terminal GFP tag. The individual *ABC1*, *ABC11* and *ABC1-ABC11* chimera ORFs are indicated below the bar charts. The values represent duplicate measurements of three independent transformants (there was no variation between individual MIC values of the same construct). (B) Inhibitor sensitivities of *S. cerevisiae* AD∆ overexpressing Abc1p (top right) or Abc11p (top left) from B2399 or Abc11p from 89102 (bottom left) were analyzed by agarose diffusion assays on CSM plates containing FLC at 0.13 × MIC~FLC~. Paper disks contained: 1 µg each of milbemycins α11; α26; β9; and β11; 5 µg FK506 (FK); 0.5 µg ENI; 1 µg beauvericin (B), or 50 nmol OLI. Plates were incubated at 30° for 72 h or until growth inhibitory zones became clearly visible. The plates are representative of at least three independent experiments. Drugs on their own were not toxic to the cells (data not shown).](1619fig8){#fig8}

Differences were also observed in relative sensitivities conferred by Abc1p and Abc11p to known efflux pump inhibitors. Milbemycins (see [Figure S11](http://www.genetics.org/highwire/filestream/436283/field_highwire_adjunct_files/2/FigureS11.pdf)) are acaricides, insecticides, and anthelmintics widely used in agriculture and veterinary medicine. FK506 is a commonly used immunosuppressor, ENI and beauvericin are ionophoric depsipeptides with antibiotic and insecticidal activities, and OLI is an ATPase inhibitor. Abc1p was more sensitive than Abc11p to all eight efflux pump inhibitors tested, especially milbemycin β11 ([Figure 8B](#fig8){ref-type="fig"}), and, as expected, Abc11p of 89102 conferred inhibitor sensitivities that were between those for Abc1p and Abc11p of B2399 ([Figure 8B](#fig8){ref-type="fig"}) because it contains elements of Abc1p (pump strain A in [Figure 8A](#fig8){ref-type="fig"}).

SF demonstrated by Abc1p and Abc11p {#s29}
-----------------------------------

The 18 core aa differences between Abc1p and Abc11p in TMS3, -4, -6, -7 and -11 ([Figure 6C](#fig6){ref-type="fig"}) clearly provided *C. krusei* with two distinct biological functions. V582I (IL1) and T795A (TMS6; [Figure 6C](#fig6){ref-type="fig"}) were allelic variations. Because *ABC12* shared a common ancestor with *ABC1* and *ABC11* ([Figure 6B](#fig6){ref-type="fig"}), we compared the 18 core aa differences between *C. krusei* Abc1p and Abc11p with Abc12p to infer which had likely changed from their common ancestor. In addition, to ascertain which of these changes were possibly fate determining, we assessed the severity of changes by comparing them with 53 fungal homologs \[see [Figure S8](http://www.genetics.org/highwire/filestream/436283/field_highwire_adjunct_files/10/FigureS8.pdf) and [@bib42])\]. It appeared that Abc1p experienced only 5 aa (green and red circles on [Figure 6C](#fig6){ref-type="fig"}) and Abc11p 16 aa (blue and red circles on [Figure 6C](#fig6){ref-type="fig"}) changes compared to their common ancestor, three of which were changes to the same position in both transporters (red circles; [Figure 6C](#fig6){ref-type="fig"}). The most significant changes, not found in any of the other 53 fungal homologs, have thick circles on [Figure 6C](#fig6){ref-type="fig"}. Abc11p experienced the majority of changes, which is also reflected in the maximum likelihood tree for the concatenated sequences of patches II--V (see [Figure S9B](http://www.genetics.org/highwire/filestream/436283/field_highwire_adjunct_files/11/FigureS9.pdf)). Compared to 53 fungal homologs, Abc11p had a unique V616 at the bottom of TMS3, and a unique V1201 at the bottom of TMS7, and Abc1p had two unique amino acids, M628 and G1209, near the top of TMS3 and the center of TMS7 (thick circles; [Figure 6C](#fig6){ref-type="fig"}). Most changes were in, or near, the predicted lipid-facing surfaces (LIPS) of individual TMSs (see [Figure S12](http://www.genetics.org/highwire/filestream/436283/field_highwire_adjunct_files/3/FigureS12.pdf)). Four of the five changes predicted to face the substrate-binding pocket in Abc11p were either too high (TMS3, -4 and -6) or too low (TMS7) to contribute directly to the substrate-binding pocket, leaving S1355, at the center of TMS11, the only candidate likely to directly interact with substrates.

Sub-NF of the regulatory control of ABC1, ABC11, and ABC12 {#s30}
----------------------------------------------------------

A genome-wide study of the evolution of *cis*-regulatory elements in duplicated genes in yeast found that the number of shared motifs rapidly decreased with time, whereas the total number of *cis*-regulatory motifs remained constant ([@bib61]). This suggested that NF played an important role in the evolution of duplicated genes in yeast ([@bib61]). Similar studies in yeast and humans later showed that most duplicated genes evolved by rapid SF followed by prolonged NF, a model termed sub-neo-functionalization (SNF) ([@bib24]).

To test whether the regulatory control of *ABC1* and *ABC11* also evolved by SNF, and to confirm possible NF of *ABC12*, we searched their promoters with the YeTFaSCo database ([@bib15]; [@bib28]) for possible yeast transcription factor binding sites (TFBSs; [Figure 9](#fig9){ref-type="fig"}). As expected, we found similar numbers of regulatory motifs in each promoter (13 in *ABC1*, 14 in *ABC11*, 16 in *ABC12*; [Table 3](#t3){ref-type="table"} and [Figure 9](#fig9){ref-type="fig"}). The *ABC1* promoter shared only four TFBSs (*HCM1*, *GTS1*, and two GCR1) with the *ABC11* promoter, and three TFBSs (*PDR3* and two *STB5*) with the *ABC12* promoters, and the *ABC11* promoter shared five TFBSs (*YAP3*, *AFT2*, *GAT1*, and two *MSN2*/*4*) with the *ABC12* promoter, but no TFBS were shared between all three promoters. The *ABC1* promoter had five (*PDR1*, *AZF1*, *UME6*, and two *SUM1*), the *ABC11* promoter two (*HAA1* and *ARO80*), and the *ABC12* promoter eight (*PDR8*, *YRR1*, *CRZ1*, *RIM101*, *ARR1*/*YAP8*, *STB3*, *DAT1*, and *STE12*) unique TFBSs ([Table 3](#t3){ref-type="table"}). Regulation of expression of PDR transporters involves a complex network of transcription factors (TFs) belonging to the PDR network (*i.e.*, *PDR1*, *PDR3*, *PDR8*, *YRR1*, and *STB5*), and often involves TFs of the general stress response (*i.e.*, *MSN2*, *MSN4*, *YAP3*, and *CRZ1*; ([@bib69])). Interestingly, *ABC12* had evolved five TFBSs of the PDR network and four TFBSs of the general stress response network, whereas regulation by these two networks was clearly divided between *ABC1* (five for PDR) and *ABC11* (six for general stress response; [Table 3](#t3){ref-type="table"} and [Figure 9](#fig9){ref-type="fig"}).

![Yeast transcription factor binding sites (TFBSs) identified in *ABC1* (A), *ABC11* (B), and *ABC12* (C) promoters. Start and stop codons, predicted TATA-boxes and the poly-A binding site for the *ABC11* terminator are in bold-type italics. The YeTFaSCo database was used to search for *S. cerevisiae* TFBSs in the upstream regions of *ABC11* (1 kb), *ABC1* (662 bp), and *ABC12* (1 kb) ([@bib15]; [@bib28]). Sequences were searched for "Expert Curated no-dubious sorts" of TFBSs using a 90% similarity cut-off. Only "meaningful" TFBSs (*i.e.*, TFBSs that are unlikely to occur randomly; binding sites \>6 nt) were considered. TFBSs are highlighted in bold-type and marked, above, with colored bars with their orientation indicated. TFBSs involved in pleiotropic drug resistance are in different shades of red. TFBSs involved in the general stress response are in different shades of green. TFBSs involved in response to different environmental conditions \[*i.e.*, resistance to arsenic (*ARR1*), iron homeostasis and resistance to oxidative stress (*AFT2*), acetic acid stress (*HAA1*), and adaptation to alkaline stress (*RIM101*)\] are in shades of blue. TFBSs involved in the diauxic shift and hypoxia are in shades of green-yellow. TFBSs involved in glycolysis and nitrogen metabolism are in yellow-orange-brown, and TFBSs involved in mitosis, meiosis, mating, and/or sporulation are in shades of gray or black.](1619fig9){#fig9}

###### List of *S. cerevisiae* TFBSs identified in the promoters of *C. krusei ABC1*, *ABC11*, and *ABC12*

                                               Groups of TFBSs                                                                                       
  -------------------------------------------- ----------------- --- --- --- --- --- --- --- --- --- --- --- --- --- --- --- --- --- --- --- --- --- ---
  * ABC1*[*^b^*](#t3n2){ref-type="table-fn"}   1                 2           2                                       1   1   2           1   2       1
  * ABC11*                                                                       2       4   1           1               1   2   1   1               1
  * ABC12*                                                       1   1   1   2   2   1   1       1   1   1   1   1               1               1   

1=*PDR1*, 2=*PDR3*, 3=*PDR8*, 4=*YRR1*, 5=*STB5*, 6=*MSN2*/*4*, 7=*CRZ1*, 8=*YAP3*, 9=*HAA1*, 10=*RIM101*, 11=*ARR1*/*YAP8*, 12=*AFT2*, 13=*STB3*, 14=*DAT1*, 15=*AZF1*, 16=*HCM1*, 17=*GCR1*, 18=*GAT1*, 19=*ARO80*, 20=*UME6*, 21=*SUM1*, 22=*STE12*, 23=*GTS1*.

662 bp *ABC1* and 1000 bp *ABC11* and *ABC12* upstream sequences were searched for potentially meaningful TFBSs (numbers indicate how many times that site was detected; also see [Figure 9](#fig9){ref-type="fig"}).

Discussion {#s31}
==========

The C. krusei population is surprisingly homogenous {#s32}
---------------------------------------------------

This study provides important insights into the population structure of *C. krusei*. There was surprisingly little sequence difference between isolates from vastly different locations, and, importantly, our data suggest that clinical (*i.e.*, 89021, 89221, 89102, 90147, and V2b) *C. krusei* isolates may be of environmental origin. Although generally considered diploid, one *C. krusei* strain (89102) was aneuploid and B2399 was triploid, which is not uncommon in yeast and possibly a response to environmental stress. B2399 may have gained an additional set of chromosomes in the same way as some triploid *D. bruxellensis* hybrid strains ([@bib6]). *D. bruxellensis* is a close relative of *C. krusei*, and a major contaminant of industrial fermentations in biofuel production and the Australian wine industry ([@bib6]). It is also possible that B2399 is triploid as a result of a failure in cell division, but that would have had to happen in the distant past given its three distinct sets of chromosomes with typical SNP frequencies.

We have previously shown that the constitutive expression of Abc1p may tip the balance in favor of innate azole resistance for *C. krusei* ([@bib41]). In this report, we show that there may yet be other factors contributing to the innate azole resistance of *C. krusei*, namely the expression of additional multidrug efflux transporters Abc11p and Abc12p.

First direct estimates for the EGC rate and the MEPS and evidence for GC-bias of EGC in C. krusei {#s33}
-------------------------------------------------------------------------------------------------

*ABC1* and *ABC11* are an exemplary pair of tandem-duplicated genes that enabled a detailed analysis of the major forces shaping their evolution. The striking pattern of identical sequences interspersed by four short (158, 19, 73, and 1 nt), highly divergent (22.2% dissimilarity), and strongly protected, sequences is a predicted outcome for the concerted evolution of tandem-duplicated paralogs of distinct function ([@bib30]). Interestingly, *ABC1* and *ABC11* initially appeared to have experienced concerted evolution for \>70 MY, which is significantly longer than the previous estimate of 25 MY for the average period of concerted evolution in yeast ([@bib22]). However, the discovery of the "same" pair of tandem-duplicated paralogs in *P. membranifaciens* extended that estimate to \>134 MY.

Because the five DNA tracts that were homogenized by frequent EGCs varied from 0.3 to 1.7 kb in size ([Table 2](#t2){ref-type="table"}), and they were separated by an equal distance (5.3 kb; [Figure 5A](#fig5){ref-type="fig"}), and because we obtained polymorphism data for a set of *C. krusei* alleles representative of the entire *C. krusei* population \[*e.g.*, no additional *ABC1*- or *ABC11*-specific SNPs were detected in any of the three *C. krusei* whole genome shotgun (WGS) sequenced strains\] it was possible to obtain, to our knowledge for the first time, a direct empirical estimate for the *C. krusei* gene conversion rate and the MEPS. The gene conversion rate increased proportionately with the tract length, and was ∼38--480× higher than the estimated silent-site nucleotide substitution rate for yeast. However, depending on the true nucleotide substitution rate of *C. krusei*, these estimates could be up to ∼8× lower (*i.e.*, ∼5--60) or ∼2× higher (*i.e.*, ∼76--960). The calculated MEPS for *C. krusei* was 106 bp. These results were in reasonable agreement with previous "indirect" estimates of 10--100× higher gene conversion than nucleotide substitution rates, and a MEPS of ∼200 bp for yeast (reviewed in [@bib48]), although our data suggest that previous estimates may have been slightly conservative. The GC-bias of gene conversion was also confirmed.

Gene deletions and CNVs combined with frequent EGCs between tandem-duplicated genes provide additional means for the evolution of novel gene function {#s34}
-----------------------------------------------------------------------------------------------------------------------------------------------------

Three out of seven strains possessed gene deletions and CNVs that, together with frequent EGCs between individual gene copies, created additional *ABC11-1* and *ABC1-11* chimeras with significantly altered functions. We previously characterized 28 different TMD chimeras between *C. albicans* Cdr1p and Cdr2p, two closely related paralogs ([Figure 6B](#fig6){ref-type="fig"}) ([@bib27]), and, in that study as well, many chimeras were severely altered in their substrate specificity and inhibitor sensitivities ([@bib71]). It would appear that creating chimeras, and/or exchanging regulatory elements between duplicated paralogs, by intramolecular or intermolecular (non)homologous recombination and/or EGC are important evolutionary forces creating novel functionality.

Model for the evolution of C. krusei ABC11, ABC1, and ABC12 {#s35}
-----------------------------------------------------------

The discovery of *ABC12* and *P. membranifaciens ABC11-ABC1* was critical for unraveling the evolutionary history of *C. krusei ABC1* and *ABC11* ([Figure 10](#fig10){ref-type="fig"}). *ABC12* appeared to be the product of gene-duplication by retrotransposition (step 1) of their common ancestor ∼149 MYA ([Table 1](#t1){ref-type="table"}), causing the loss of at least two inferred introns. The ancestor of *ABC1* or *ABC11* deintronized (step 4) one of these introns possibly soon after duplication (step 3), and before speciation of the *C. krusei* and *P. membranifaciens* lineages ∼134 MYA, which may have caused a temporary pseudogene. A functional ORF was recovered (step 5) not long after by a 10 bp insertion, and the deintronized version was then copied by EGC (step 6) onto its neighboring duplicate. The *ABC1* and *ABC11* ancestors optimized their efflux pump functions by SF of their common ancestor *ABC1*/*11*′. While the majority of their ORFs have evolved by concerted evolution for ∼134 MY, four small stretches of *C. krusei ABC1* and *ABC11* have been under very strong purifying selection (step 7), which led to an extremely clear pattern of sequence identity interspersed by very short peaks of sequence divergence. *ABC12*, on the other hand, is likely to have evolved by NF of both its regulatory control and pump function (step 2) since its retrotransposition into a completely different part of the genome. The experimental evidence indicates that, although all three genes are under very strong purifying selection, *ABC1*, *ABC11*, and *ABC12* are not dosage sensitive genes, and one gene copy appears to be enough for the survival of *C. krusei* (triploid B2399 and diploid IFO0011 each had only one intact *ABC1* and *ABC11* gene copy, and diploid strains 89021, 89221, and 90147 each had only one intact *ABC12* gene copy).

![Model for the evolution of *C. krusei ABC1*, *ABC11*, and *ABC12*. The common ancestor (ancestors are indicated with apostrophes after their names) *ABC1*/*11*/*12*′ contained at least two N-terminal introns (gray). *ABC12*′ duplicated ∼156 MYA by retrotransposition (1) into another part of the genome, and evolved its own unique function and expression pattern (2). Not long after, ∼134 MYA, the *ABC1/11*′ ancestor tandem-duplicated (3). Soon after, *ABC11* deintronized the N-terminal intron (4), which may have caused a temporary pseudogene. Function was possibly recovered by a 10 bp insertion downstream (5). The *ABC1*′ ancestor then adopted the deintronized copy of *ABC11*′ by gene conversion (6) possibly not long after recovery of the *ABC11*′ ORF. The order of individual events may differ from the one outlined here. A critical proline change in TMS3 of *ABC11*′ (P616V) was possibly fate-determining, and caused SF (7) of Abc1p and Abc11p, but the majority of their ORFs evolved by continuing concerted evolution. The regulatory regions, on the other hand, evolved by SNF with no visible homologies remaining in the 5′ and 3′ proximal regions.](1619fig10){#fig10}

*P. membranifaciens ABC1* and *ABC11* followed a different evolutionary trajectory after speciation from *C. krusei*, maybe to compensate for the loss of the third multidrug efflux pump *ABC12*. Like *C. krusei ABC1* and *ABC11*, however, they too experienced concerted evolution for ∼134 MY, and exhibit a unique pattern of sequence identities interspersed with stretches of sequence divergence. Interestingly, the nitrate assimilating Saccharomycotina yeast *Candida utilis* also has similar PDR multidrug efflux pump tandem-duplicates that were difficult to assemble because of the complex DNA patterns caused by concerted evolution ([@bib76]). It would seem that prolonged concerted evolution of tandem-duplicates is perhaps more common than generally assumed, at least in the case of PDR transporters.

Different types of intron loss in C. krusei PDR transporters {#s36}
------------------------------------------------------------

Because all Saccharomycotina cluster A PDR transporters share a common ancestor with *ABC1*, *ABC11*, and *ABC12* ([Figure 6B](#fig6){ref-type="fig"}), it is likely that these too contained at least two introns, which they have lost by a number of independent retrotransposition events. We also identified one N-terminal intron each in both *C. krusei* homologs of *S. cerevisiae PDR12* encoding a weak organic acid transporter ([@bib62]). Both predicted proteins were highly homologous to *S. cerevisiae* Pdr12p (75 and 77% identity, respectively), and 86% homologous to each other. We therefore named them *PDR12* (SD108 scaffold 20: 24,998--29,583) and *PDR121* (*i.e.*, *PDR12* one; SD108 scaffold 7: 101,770--106,331). Although the ORF sequences were almost identical, their introns varied in size from 103--104 (*PDR12*) to 66--80 (*PDR121*) nucleotides between the three WGS sequences. This was in contrast to the *C. krusei ABC1* and *ABC11* intron, which was identical for all A and B alleles, demonstrating the overpowering force of EGC between closely linked and highly similar stretches of DNA that are under no or little positive selection. Thus, similar to the *ABC1*/*11*/*12*′ ancestor, the common ancestor of the *PDR12* homologs had at least two introns, because the *PDR12* and *PDR121* introns clearly had distinct origins (*i.e.*, they were inserted 49 aa apart, just after K209 and K258, respectively---a highly conserved region of NBD1 between the Q-loop and the ABC signature motif; see [Figure S8](http://www.genetics.org/highwire/filestream/436283/field_highwire_adjunct_files/10/FigureS8.pdf)). Because *PDR121* lacked the *PDR12* intron just after K209, *PDR121* likely lost this ancestral intron by homologous recombination between a cDNA copy of its mRNA and the region surrounding that intron. However, unlike *PDR12* and *PDR121*, that each had two polypyrimidine tracts, one before and one after the BS signal, and *P. membranifaciens ABC11* and *ABC1*, that each had one polypyrimidine tract after the BS signal ([Figure 7C](#fig7){ref-type="fig"}), the conserved *C. krusei ABC1-ABC11* intron had no polypyrimidine tract. However, the 31 nt between its BS and 3′ ss signal was well within the maximum 45 nt required for efficient mRNA splicing in yeast ([@bib51]). Although yeast genes contain few introns \[*S. cerevisiae* contains, on average, 0.05 per gene ([@bib25]) compared to 8.1 introns per gene for *H. sapiens* ([@bib31])\], it is now commonly accepted that the fungus-animal ancestor had an intron density comparable to the highest known modern intron densities, underscoring the importance of intron loss during eukaryotic evolution ([@bib70]). It seems that *ABC1* and *ABC11*, as well as *PDR12* and *PDR121*, are "ancient" transporters that have not yet lost all their introns.

Gene duplication, a possibly fate determining proline change, and (S)NF of the regulatory control enabled the evolution of distinct biological functions {#s37}
--------------------------------------------------------------------------------------------------------------------------------------------------------

Since 2006, a number of structures for bacterial ([@bib14]), lower eukaryotic ([@bib33]; [@bib35]), and mouse ([@bib2]) ABCB-type multidrug efflux transporters, functional homologs of PDR transporters, have been solved. The structures revealed a centrally located substrate-binding cavity ([@bib14]; [@bib2]; [@bib33]) into which substrates enter from the inner leaflet of the bilayer via a gate formed by a "flexible" TMS4 caused by strategically positioned G and P residues ([@bib35]). A high frequency of helix kinks, often caused by P residues, is one of the hallmarks of membrane protein structure ([@bib82]). Unique G and P residues were also involved in the evolution of Abc1p and Abc11p. It is possible that the unique P change at the bottom of TMS3 of Abc11p (P616V) may have been fate-determining, and induced the SF of Abc1p and Abc11p. Changing the conserved proline-kink at the bottom of TMS3 of Abc11p by an angle of ∼100° possibly caused significant TMS packing disorder, which was compensated for by changes to TMS3, TMS4, IL2, TMS6, TMS7, and TMS11 ([Figure 6C](#fig6){ref-type="fig"}), the majority of which were along one face of TMS3 (four changes) and TMS7 (four changes; see [Figure S12](http://www.genetics.org/highwire/filestream/436283/field_highwire_adjunct_files/3/FigureS12.pdf)). The involvement of the TMS7 surface, which includes G1209 as well as V1201, V1205, V1209, and I1213 of Abc11p, in critical helical rearrangements (*i.e.*, helix--helix contacts) during the transport cycle of PDR transporters was previously noted by [@bib36], who found that an A1208V mutation of *C. albicans* Cdr1p (equivalent to S1212 of Abc11p, which is also part of that surface; see [Figure S12](http://www.genetics.org/highwire/filestream/436283/field_highwire_adjunct_files/3/FigureS12.pdf)) dramatically altered its substrate transport activities ([@bib36]).

As a consequence of the changes to Abc11p, Abc1p function may have been optimized by modulation of amino acids in TMS3, TMS6, and TMS7, with M628 and G1209 possibly critically important for that process ([Figure 6C](#fig6){ref-type="fig"}). There is also strong evidence that S1355N, the patch V Abc11p/Abc1p amino acid at the center of TMS11 and possibly facing the substrate-binding pocket (see [Figure S12](http://www.genetics.org/highwire/filestream/436283/field_highwire_adjunct_files/3/FigureS12.pdf)), is important for substrate transport and inhibitor sensitivity. Mutation of the equivalent amino acid in *S. cerevisiae* Pdr5p (S1360A/F) and *C. albicans* Cdr1p (T1351A/F) severely affected substrate transport, and also eliminated the pumps' sensitivities to FK506 ([@bib18]; [@bib66]).

In the absence of better alternatives, the YeTFaSCo database provides a valuable tool for the search of TFs that possibly regulate gene expression in members of the Saccharomycotina family. Our discovery of functionally related TFBSs was consistent with the SNF of the regulatory controls of *ABC1* and *ABC11*, and the NF of the regulatory control of *ABC12*.

Summary {#s38}
-------

*C. krusei* is an innately azole resistant diploid fungal pathogen with a tendency to create aneuploid strains or triploid hybrids when exposed to environmental stress. This study confirms that it belongs to a third major Saccharomycotina lineage that has yet to be classified. A detailed study of the tandem-duplicated multidrug efflux pump genes *ABC11* and *ABC1* (a) provided the first empirical estimates for the gene conversion rate and the size of the MEPS for any eukaryotic organism; (b) confirmed GC-bias for EGC in *C. krusei*; (c) revealed concerted evolution for the majority of the two ORFs lasting for \>134 MY; and (d) highlighted the importance of gene deletions, nonhomologous mitotic recombination, and CNVs combined with frequent EGCs between tandem-duplicated genes, for the evolution of novel functionality. We also provided first examples of intron loss by retrotransposition, deintronization, and, possibly, also by homologous recombination for any fungal PDR transporter. Discovery of a third *C. krusei* multidrug efflux transporter, *ABC12*, and the discovery of the tandem-duplicated orthologs *P. membranifaciens ABC1* and *ABC11*, helped unravel the evolutionary history of an entire ABC transporter multi-gene family. It revealed a unique proline-kink change at the bottom of TMS3 of *C. krusei ABC11* that possibly sealed the fate of Abc11p and induced the SF of *ABC1* and *ABC11*. The regulatory control of *ABC1* and *ABC11*, however, "escaped" concerted evolution and appeared to have evolved by SNF. We propose that, given the experimental difficulties in recognizing and correctly assembling highly similar, tandem-duplicated, gene sequences, their abundance, and, in turn, the impact of EGC on gene duplication and evolution, may be significantly underestimated by the scientific community.

Supplementary Material {#s39}
======================

Supplemental material is available online at [www.genetics.org/lookup/suppl/doi:10.1534/genetics.116.194811/-/DC1](http://www.genetics.org/lookup/suppl/doi:10.1534/genetics.116.194811/-/DC1).
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